Log in

4154 Raku Co..Ltd TPEX · Taiwan

Raku Co..Ltd (4154) news

Raku Co..Ltd is a public biotech or pharmaceutical company listed on TPEX under the ticker 4154, recorded under Taiwan. The directory classifies it as Pharmaceuticals: Generic. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Raku Co..Ltd news

We have not published a story on Raku Co..Ltd yet. When there is news, it will appear here.

Questions about Raku Co..Ltd

What is the ticker symbol of Raku Co..Ltd?

Raku Co..Ltd trades under the ticker 4154 on TPEX.

Where is Raku Co..Ltd listed?

Raku Co..Ltd is listed on TPEX.

Which country or territory is Raku Co..Ltd listed under?

Our directory records Raku Co..Ltd under Taiwan.

What does Raku Co..Ltd do?

Our directory classifies Raku Co..Ltd as: Pharmaceuticals: Generic. This is a directory classification, not a description of the pipeline.

What is the ISIN of Raku Co..Ltd?

The ISIN recorded for Raku Co..Ltd is KYG527551082.

Does aibio.space cover Raku Co..Ltd?

aibio.space lists Raku Co..Ltd among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Raku Co..Ltd?

Companies in our directory listed in the same country and business area as Raku Co..Ltd: Pharmigene, Intelligene, Anxo Pharmaceutical Co., Chunghwa Chemical Synthesis & Biotech Co., Mycenax Biotech, MegaPro Biomedical Co..

Investor discussion: Raku Co..Ltd

Members talk about Raku Co..Ltd (4154). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TPEX:4154 on TradingView.

Listing details

Raku Co..Ltd is a public biotech or pharmaceutical company listed on TPEX under the ticker 4154, recorded under Taiwan. The directory classifies it as Pharmaceuticals: Generic. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Raku Co..Ltd
Ticker
4154
Listing
TPEX
Country or territory
Taiwan
Business scope
Pharmaceuticals: Generic
ISIN
KYG527551082
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.